Metropolis Healthcare Limited (BOM:542650)
India flag India · Delayed Price · Currency is INR
556.65
+16.00 (2.96%)
At close: Aug 21, 2026

Metropolis Healthcare Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,9001,4501,2781,4292,142
Depreciation & Amortization
1,125892.3846.45806.27562.1
Other Amortization
212.08194.5298.2385.8970.13
Loss (Gain) From Sale of Assets
6.83-17.59--0.080.16
Asset Writedown & Restructuring Costs
---1.352.22
Loss (Gain) From Sale of Investments
-33.84-75.06-11.56-6.78-4.26
Stock-Based Compensation
80.7470.0814.162.8568.57
Provision & Write-off of Bad Debts
278.7397.09113.52-21.72-28.48
Other Operating Activities
469.28173.58247.21103.19-115.54
Change in Accounts Receivable
-489.68-118.89-123.7157.72115.87
Change in Inventory
32.3218.7558.9865.15-79.37
Change in Accounts Payable
-22.848.3857-53.12-165.07
Change in Other Net Operating Assets
-52.01-105.3862.24-98.64-35.41
Operating Cash Flow
3,5072,6272,6412,4712,533
Operating Cash Flow Growth
33.47%-0.50%6.87%-2.44%1.70%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-434.89-434.1-637.61-526.34-306.63
Sale of Property, Plant & Equipment
2.720-1.49-
Cash Acquisitions
-1,134-1,312-6.5-4.51-6,379
Sale (Purchase) of Intangibles
-76.95-252.02---
Investment in Securities
-606.66-48.32-271.66932.29-800.44
Other Investing Activities
18.6915.7721.6565.01110.62
Investing Cash Flow
-2,231-2,011-894.12467.94-7,376

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
45.37---6,000
Total Debt Issued
45.37---6,000
Long-Term Debt Repaid
-812.66-680.87-1,382-2,242-3,791
Total Debt Repaid
-812.66-680.87-1,382-2,242-3,791
Net Debt Issued (Repaid)
-767.29-680.87-1,382-2,2422,209
Issuance of Common Stock
0.070.10.031.8419.75
Common Dividends Paid
-207.29--204.96-409.69-409.38
Other Financing Activities
-178.43-185.57-224.8-273.24-194.48
Financing Cash Flow
-1,153-866.34-1,812-2,9231,625

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
24.639.83.2512.97-13.64
Miscellaneous Cash Flow Adjustments
5.78.21-0-25.29
Net Cash Flow
153.08-231.43-62.1528.53-3,206

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
3,0722,1932,0031,9452,226
Free Cash Flow Growth
40.06%9.50%3.01%-12.65%0.84%
Free Cash Flow Margin
18.67%16.48%16.59%16.94%18.12%
Free Cash Flow Per Share
14.8610.609.749.4610.82
Levered Free Cash Flow
2,4281,5521,8401,2801,723
Unlevered Free Cash Flow
2,5811,6681,9811,4481,846

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
244.03185.57224.8273.24183.84
Cash Income Tax Paid
454.85439.75373.84515.8825.12
Change in Working Capital
-532.17-157.1354.5271.11-163.98